Emerging Immunotherapeutics for Ovarian Cancer Symposium
September 23, 2021
Virtual
FUJIFILM Diosynth Biotechnologies is delighted to be exhibiting at the Emerging Immunotherapeutics for Ovarian Cancer Virtual Symposium , September 23, 2021. Connect with the Commercial Development team to learn more about our capabilities and how we could help you advance and deliver tomorrow’s medicines.
“The Antibody Society, in collaboration with the Ovarian Cancer Research Alliance (OCRA), is pleased to present the Emerging Immunotherapeutics for Ovarian Cancer Symposium. The mission of OCRA is to cure ovarian cancer, advocate for patients, and support survivors. The aim of this event is to spread knowledge and awareness around current and up-and-coming basic and clinical research on the use of antibody and immune therapeutics for the treatment of ovarian cancer.”
For the full agenda and registration click here